Viking Therapeutics, Inc. VKTX
Set alert
27.28 USD +0.42 +1.56%
At close · Oct 30
27.04 -0.24 -0.88%
After hours · Oct 30, 7:28 PM ET
26.31 Day range 27.83
24.21 52-week range 42.13
- YTD
- -22.46%
- 1 year
- -28.53%
- Open
- 26.69
- Prev close
- 26.86
- Mkt cap
- 3.48B
- Vol
- 5.14M
- Avg vol
- 4.74M
- EPS
- -5.42
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 26.31
- High
- 27.83
- Forward P/E
- -5.39
- Beta
- 0.65
- Short ratio
- 2.88
- Inst. own
- 60.24%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 10, 2027
- 50-d avg
- 30.65
- 200-d avg
- 32.44
- 1y target
- 95.32
Financial health
Altman Z-Score
2.38 Grey zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C-1 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 2
- P/E 1
- P/B 1
Valuation
P/E -11.0×
FY 2016 5y median -11.0× FY 2025
P/S 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 6.2×
FY 2016 5y median 5.0× FY 2025
P/FCF -14.2×
FY 2016 5y median -14.9× FY 2025
EV/EBITDA -10.6×
FY 2016 5y median -10.6× FY 2025
EV/Sales 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -7.0%
FY 2016 5y median -6.7% FY 2025
Profitability
Gross Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -56.3%
FY 2016 5y median -27.2% FY 2025
ROIC -61.5%
FY 2016 5y median -28.8% FY 2025
ROA -50.2%
FY 2016 5y median -26.1% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2016 FY 2025
Operating Income -160.6%
FY 2016 FY 2025
EPS (diluted) -215.8%
FY 2016 FY 2025
Free Cash Flow -217.4%
FY 2016 FY 2025
Financial Health
Current Ratio 9.3×
FY 2016 5y median 19.2× FY 2025
Quick Ratio 9.3×
FY 2016 5y median 19.2× FY 2025
Debt / Equity 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.5×
FY 2016 5y median 0.5× FY 2025
Interest Coverage 0.0×
FY 2016 5y median -1192× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31